title: Platelet monitoring follow-up in a pregnant patient with HELLP syndrome.
abstract: Monitoring the course of platelet function in HELLP (haemolysis, elevated liver-enzymes and low platelets) syndrome is important for clinical decision-making. We present a primigravid woman developing HELLP syndrome at 29 weeks and 6 days. Platelet function was monitored by multiple electrode aggregometry (MEA), platelet function analyzer (PFA-100®), platelet count and mean platelet volume (MPV) over an 11-day period. MPV and PFA-100® seem better predictors for platelet function than platelet levels.
authors.affiliation: Department of Anaesthesiology and Pain Treatment, Maastricht University Medical Centre (MUMC), Maastricht, the Netherlands.
authors.forename: Gerhardus J A J M
authors.initials: GJ
authors.lastname: Kuiper
authors.forename: Marcus D
authors.initials: MD
authors.lastname: Lancé
authors.forename: Valerie M
authors.initials: VM
authors.lastname: Smit-Fun
authors.forename: Louis L H
authors.initials: LL
authors.lastname: Peeters
authors.forename: Marco A E
authors.initials: MA
authors.lastname: Marcus
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001792:Blood Platelets / Q000166:cytology / Q000378:metabolism*; D005260:Female; D017359:HELLP Syndrome / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D010976:Platelet Count; D011247:Pregnancy; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents